Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites

被引:111
作者
Qian, H
Wang, T
Naumovski, L
Lopez, CD
Brachmann, RK
机构
[1] Washington Univ, Sch Med, Div Oncol, Dept Med, St Louis, MO 63110 USA
[2] Stanford Univ, Div Hematol Oncol & Stem Cell Transplantat, Stanford, CA 94305 USA
[3] Oregon Hlth Sci Univ, Dept Med, Div Hematol & Med Oncol, Portland, OR 97201 USA
关键词
apoptosis; cell cycle; DNA binding site; DNA repair; p53;
D O I
10.1038/sj.onc.1205974
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor protein p53, once activated, can cause either cell cycle arrest or apoptosis through transactivation of target genes with p53 DNA binding sites (DBS). To investigate the role of p53 DBS in the regulation of this profound, yet poorly understood decision of life versus death, we systematically studied all known and potential p53 DBS. We analysed the DBS separated from surrounding promoter regions in yeast and mammalian assays with and without DNA damage. p53 efficiently utilized the DBS of MDM2 and of genes connected to cell cycle arrest, DNA repair and the death receptor pathway of apoptosis. However, p53 was unable to utilize two-thirds of the isolated DBS, a subset that included almost all DBS of apoptosis-related genes. Neither ASPP2, a p53-interacting protein reported to specifically stimulate p53 transcriptional activity on apoptosis-related promoters, nor DNA damage resulted in p53 utilization of isolated DBS of apoptosis-related genes. Thus, a major regulation of p53 activity occurs at the level of p53 DBS themselves by posing additional requirements for the successful utilization of apoptosis-related DBS.
引用
收藏
页码:7901 / 7911
页数:11
相关论文
共 42 条
[1]   SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53 [J].
BAKER, SJ ;
MARKOWITZ, S ;
FEARON, ER ;
WILLSON, JKV ;
VOGELSTEIN, B .
SCIENCE, 1990, 249 (4971) :912-915
[2]   Mechanisms of p53-mediated apoptosis [J].
Bates, S ;
Vousden, KH .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (01) :28-37
[3]   Dominant-negative p53 mutations selected in yeast hit cancer hot spots [J].
Brachmann, RK ;
Vidal, M ;
Boeke, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) :4091-4095
[4]   Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations [J].
Brachmann, RK ;
Yu, KX ;
Eby, Y ;
Pavletich, NP ;
Boeke, JD .
EMBO JOURNAL, 1998, 17 (07) :1847-1859
[5]   p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements [J].
Campomenosi, P ;
Monti, P ;
Aprile, A ;
Abbondandolo, A ;
Frebourg, T ;
Gold, B ;
Crook, T ;
Inga, A ;
Resnick, MA ;
Iggo, R ;
Fronza, G .
ONCOGENE, 2001, 20 (27) :3573-3579
[6]   A polymorphic microsatellite that mediates induction of PIG3 by p53 [J].
Contente, A ;
Dittmer, A ;
Koch, MC ;
Roth, J ;
Dobbelstein, M .
NATURE GENETICS, 2002, 30 (03) :315-320
[7]   Two new p73 splice variants, γ and δ, with different transcriptional activity [J].
De Laurenzi, V ;
Costanzo, A ;
Barcaroli, D ;
Terrinoni, A ;
Falco, M ;
Annicchiarico-Petruzzeli, M ;
Levrero, M ;
Melino, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (09) :1763-1768
[8]  
Di Como CJ, 1998, ONCOGENE, V16, P2527
[9]   DEFINITION OF A CONSENSUS BINDING-SITE FOR P53 [J].
ELDEIRY, WS ;
KERN, SE ;
PIETENPOL, JA ;
KINZLER, KW ;
VOGELSTEIN, B .
NATURE GENETICS, 1992, 1 (01) :45-49
[10]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825